Ireland
--:--IST
Active, not recruiting Observational

Diagnostic and Management of Hand Infection.

NCT06630988 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2024-09-01
Last updated
2024-10-08

Condition(s) studied

Hand InfectionsIncluding WhitlowsTendinous InfectionsSeptic Arthritis

Investigational drug(s) / intervention(s)

Failure rates

Failure rates: Describe the management failure rate for hand infections, including panariasis, phlegmons and arthritis.

Study summary

Primary or secondary (post-traumatic infections, notably related to bites, wounds, etc.) infections of the hand are very common situations, even if the epidemiology is poorly understood. For example, hand bite injuries represent 1.2 million referrals to the healthcare system per year in the United States. Their nosological framework extends from simple infections of the skin and soft tissues such as whitlows, to potentially severe deep damage such as arthritis and osteitis, or phlegmons of the tendon sheaths. The diagnostic approach is not consensual, and the contribution of additional biological parameters (inflammatory syndrome) and morphological investigations (x-rays, ultrasound, CT-scan or MRI) is not codified. Microbiology seems dominated by Staphylococcus aureus, but few studies have precisely described the microbial etiology. Consequently, probabilistic antibiotic therapy and the need to take bacteriological samples for secondary adaptation are not standardized. Likewise, surgical strategies (abstention, systematic washing or depending on evolution) remain operator dependent. We consequently aim to described diagnostic, management and related outcomes or hand infections in a specialized tertiary care center.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * all patient ≥ 18 * yo followed-up for a hand infection in our tertiary care center * from 01/01/2014 to 31/12/2023, including * whitlows * tendinous infections * septic arthritis Exclusion Criteria: * osteomyelitis

Primary outcome measure(s)

  • Percentage of treatment failure during the management of hand infections. — between 01/01/2014 and 31/12/2023.
    Treatment failure will be defined as infection persistence or relapse, need of unplanned surgery for septic reason or infection-related death.

Trial sites (1)

FacilityCityRegionStatus
HCL - Hôpital Edouard Herriot Lyon France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06630988 on ClinicalTrials.gov ↗ ← All trials in France